1. Key Insights

2. Executive Summary of Frontotemporal Dementia

3. SWOT Analysis for Frontotemporal Dementia

4. Disease Background and Overview
4.1. Introduction
4.2. Stages and Symptoms of FTD
4.3. Causes
4.4. Pathophysiology
4.5. TDP 43 proteinopathy
4.6. Disease progression
4.7. Genetics
4.8. Related Frontotemporal Dementia Syndromes
4.9. Diagnosis

5. Epidemiology and Patient Population
5.1. Key Findings
5.2. 7MM Total Prevalent Patient Population of Frontotemporal Dementia (FTD)
5.3. 7MM – Epidemiology Assumptions and Rationale

6. Country-wise Epidemiology of FTD
6.1. The United States
6.1.1. Diagnosed Prevalent cases of FTD
6.1.2. Prevalent cases of FTD by type
6.1.3. Subtype- specific cases of Primary Progressive Aphasia in the United States
6.1.4. Mutations associated with FTD in the United States
6.2. EU-5
6.2.1. Germany
6.2.1.1. Diagnosed Prevalent cases of FTD
6.2.1.2. Prevalent cases of FTD by type
6.2.1.3. Subtype- specific cases of Primary Progressive Aphasia in Germany
6.2.1.4. Mutations associated with FTD in Germany
6.2.2. France
6.2.2.1. Diagnosed Prevalent cases of FTD
6.2.2.2. Prevalent cases of FTD by type
6.2.2.3. Subtype- specific cases of Primary Progressive Aphasia in France
6.2.2.4. Mutations associated with FTD in France
6.2.3. Italy
6.2.3.1. Diagnosed Prevalent cases of FTD
6.2.3.2. Prevalent cases of FTD by type
6.2.3.3. Subtype- specific cases of Primary Progressive Aphasia in Italy
6.2.3.4. Mutations associated with FTD in Italy
6.2.4. Spain
6.2.4.1. Diagnosed Prevalent cases of FTD
6.2.4.2. Prevalent cases of FTD by type
6.2.4.3. Subtype- specific cases of Primary Progressive Aphasia in Spain
6.2.4.4. Mutations associated with FTD in Spain
6.2.5. The United Kingdom
6.2.5.1. Diagnosed Prevalent cases of FTD
6.2.5.2. Prevalent cases of FTD by type
6.2.5.3. Subtype- specific cases of Primary Progressive Aphasia in The United Kingdom
6.2.5.4. Mutations associated with FTD in The United Kingdom
6.2.6. Japan
6.2.6.1. Diagnosed Prevalent cases of FTD
6.2.6.2. Prevalent cases of FTD by type
6.2.6.3. Subtype- specific cases of Primary Progressive Aphasia in Japan
6.2.6.4. Mutations associated with FTD in Japan

7. Treatment and Management
7.1. Biomarkers for FTD
7.2. Patient Journey

8. Unmet Needs

9. Case Studies
9.1. Exploring frontotemporal dementia through a case report
Title: Exploring frontotemporal dementia through a case report: An emerging public health concern in disguise
9.2. Behavioral variant FTD presenting with apathy: A case Discussion in the US

10. Appendix
10.1. Report Methodology

11. DelveInsight Capabilities

12. Disclaimer

13. About DelveInsight

List of Tables
Table 1: Summary of Frontotemporal Dementia (FTD) Market, Epidemiology, and Key Events (2017–2030)
Table 2: Frontotemporal dementia neuroimaging correlations
Table 3: Total Prevalent Patient Population of FTD in 7MM (2017–2030)
Table 4: Diagnosed Prevalent Cases of FTD in the United States (2017-2030)
Table 5: Prevalent Cases of FTD by type in the United States (2017-2030)
Table 6: Subtype- specific cases of Primary Progressive Aphasia in the United States (2017-2030)
Table 7: Mutations associated with FTD in the United States (2017-2030)
Table 8: Diagnosed Prevalent Cases of FTD in Germany (2017-2030)
Table 9: Prevalent Cases of FTD by type in Germany (2017-2030)
Table 10: Subtype- specific cases of Primary Progressive Aphasia in Germany (2017-2030)
Table 11: Mutations associated with FTD in Germany (2017-2030)
Table 12: Diagnosed Prevalent Cases of FTD in France (2017-2030)
Table 13: Prevalent Cases of FTD by type in France (2017-2030)
Table 14: Subtype- specific cases of Primary Progressive Aphasia in France (2017-2030)
Table 15: Mutations associated with FTD in France (2017-2030)
Table 16: Diagnosed Prevalent Cases of FTD in Italy (2017-2030)
Table 17: Prevalent Cases of FTD by type in Italy (2017-2030)
Table 18: Subtype- specific cases of Primary Progressive Aphasia in Italy (2017-2030)
Table 19: Mutations associated with FTD in Italy (2017-2030)
Table 20: Diagnosed Prevalent Cases of FTD in Spain (2017-2030)
Table 21: Prevalent Cases of FTD by type in Spain (2017-2030)
Table 22: Subtype- specific cases of Primary Progressive Aphasia in Spain (2017-2030)
Table 23: Mutations associated with FTD in Spain (2017-2030)
Table 24: Diagnosed Prevalent Cases of FTD in The United Kingdom (2017-2030)
Table 25: Prevalent Cases of FTD by type in The United Kingdom (2017-2030)
Table 26: Subtype- specific cases of Primary Progressive Aphasia in The United Kingdom (2017-2030)
Table 27: Mutations associated with FTD in The United Kingdom (2017-2030)
Table 28: Diagnosed Prevalent Cases of FTD in Japan (2017-2030)
Table 29: Prevalent Cases of FTD by type in Japan (2017-2030)
Table 30: Subtype- specific cases of Primary Progressive Aphasia in Japan (2017-2030)
Table 31: Mutations associated with FTD in Japan (2017-2030)
Table 32: Diagnostic Markers in Current Use in FTD

List of Figures
Figure 1: SWOT Analysis
Figure 2: Types of Frontotemporal Dementia
Figure 3: Frontotemporal Dementia spectrum
Figure 4: Total Prevalent Patient Population of FTD in 7MM (2017–2030)
Figure 5: Diagnosed prevalent cases of FTD in the United States (2017-2030)
Figure 6: Prevalent Cases of FTD by type in the United States (2017-2030)
Figure 7: Subtype- specific cases of Primary Progressive Aphasia in the United States (2017-2030)
Figure 8: Mutations associated with FTD in the United States (2017-2030)
Figure 9: Diagnosed prevalent cases of FTD in Germany (2017-2030)
Figure 10: Prevalent Cases of FTD by type in Germany (2017-2030)
Figure 11: Subtype- specific cases of Primary Progressive Aphasia in Germany (2017-2030)
Figure 12: Mutations associated with FTD in Germany (2017-2030)
Figure 13: Diagnosed prevalent cases of FTD in France (2017-2030)
Figure 14: Prevalent Cases of FTD by type in France (2017-2030)
Figure 15: Subtype- specific cases of Primary Progressive Aphasia in France (2017-2030)
Figure 16: Mutations associated with FTD in France (2017-2030)
Figure 17: Diagnosed prevalent cases of FTD in Italy (2017-2030)
Figure 18: Prevalent Cases of FTD by type in Italy (2017-2030)
Figure 19: Subtype- specific cases of Primary Progressive Aphasia in Italy (2017-2030)
Figure 20: Mutations associated with FTD in Italy (2017-2030)
Figure 21: Diagnosed prevalent cases of FTD in Spain (2017-2030)
Figure 22: Prevalent Cases of FTD by type in Spain (2017-2030)
Figure 23: Subtype- specific cases of Primary Progressive Aphasia in Spain (2017-2030)
Figure 24: Mutations associated with FTD in Spain (2017-2030)
Figure 25: Diagnosed prevalent cases of FTD in The United Kingdom (2017-2030)
Figure 26: Prevalent Cases of FTD by type in The United Kingdom (2017-2030)
Figure 27: Subtype- specific cases of Primary Progressive Aphasia in The United Kingdom (2017-2030)
Figure 28: Mutations associated with FTD in The United Kingdom (2017-2030)
Figure 29: Diagnosed prevalent cases of FTD in Japan (2017-2030)
Figure 30: Prevalent Cases of FTD by type in Japan (2017-2030)
Figure 31: Subtype- specific cases of Primary Progressive Aphasia in Japan (2017-2030)
Figure 32: Mutations associated with FTD in Japan (2017-2030)
Figure 33: Unmet needs of FTD